abstract |
The invention relates to novel 1-hydroxyimino-3-phenyl propane of the formula (See Formula) in which from R1 to R10 have the meanings defined in the description and in the claims, as well as pharmaceutically acceptable salts of the same. These compounds are GPBAR1 agonists and can be used as medicines for the treatment of diseases, for example type II diabetes. |